IMRE Corp complete private placement 400000 share security European institution 2.5 mln dlrs. The company proceeds work capital implement company's plan. IMRE establish manufacturing facility Richmond Washington make raw material component Prosorba column medical device remove disease-related immune component human bloodstream. The company await Food Drug Administration approval device. Reuter 